2016-05-11T13:34:58-05:00 2015-06-30 131639826 EISNERAMPER LLP 6900 JERICHO TURNPIKE SUITE 312 SYOSSET NY 11791 990 2014-07-01 943342838 ANIMAL CANCER FOUNDATION ANIM 8774483223 129 GLOVER AVENUE NORWALK CT 06850 BARBARA COHEN EXECUTIVE DIRECTOR 8774483223 2016-05-05 1 LOIS CLINCO P00743112 5168648900 2014 2016-08-17 19:52:53Z BARBARA COHEN 129 GLOVER AVENUE NORWALK CT 06850 382098 0 X WWW.ACFOUNDATION.ORG X 1999 CA ACF DEVELOPS AND SUPPORTS RESEARCH THAT ADVANCES THE PREVENTION AND TREATMENT OF CANCER FOR PEOPLE AND PETS. ACF FOCUSES ON FURTHERING RESEARCH IN COMPARATIVE ONCOLOGY, WHICH IS THE STUDY OF CANCERS THAT OCCUR SIMILARLY IN BOTH PETS AND HUMANS. 8 8 0 0 0 0 197281 279830 0 0 7392 12176 2103 1 206776 292007 50000 4000 0 0 66743 66819 0 0 27647 73542 73840 190285 144659 16491 147348 267881 395737 15680 6027 252201 389710 ACF DEVELOPS AND SUPPORTS RESEARCH THAT ADVANCES THE PREVENTION AND TREATMENT OF CANCER FOR PEOPLE AND PETS. ACF FOCUSES ON FURTHERING RESEARCH IN COMPARATIVE ONCOLOGY, WHICH IS THE STUDY OF CANCERS THAT OCCUR SIMILARLY IN BOTH PETS AND HUMANS. 0 0 44474 4000 1 TO FUND AND DEVELOP RESEARCH FOCUSED ON THE BIOLOGIC SIMILARITY OF CANCER IN PETS AND PEOPLE THAT WILL EXPEDITE THERAPEUTIC AND PREVENTATIVE BENEFITS FOR BOTH. ALSO, TO EDUCATE THE PUBLIC AND SCIENTIFIC COMMUNITY ABOUT THE BIOLOGIC SIMILARITY OF CANCER IN PETS AND PEOPLE, AND TO COMMUNICATE THE WAYS IN WHICH COMPARITIVE ONCOLOGY IS ACCELERATING THE TREATMENT, PREVENTION AND ULTIMATE ERADICATION OF CANCER. 44474 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 X 8 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 0 0 1 0 NY CA CO CT PA X X X BARBARA COHEN 8774483223 129 GLOVER AVENUE NORWALK CT 06850 DR GERALD S POST DVM ACVIM FOUNDER & VICE PRESIDENT 3.00 X 0 0 0 DAVID C LEVINE MD FACS MEDICAL DIRECTOR 3.00 X 0 0 0 VICKI TRINAGEL TREASURER 3.00 X 0 0 0 MATTHEW VUOLO ESQ PRESIDENT 3.00 X 0 0 0 ANNIE SELKOVITS TAYLOR BOARD MEMBER 3.00 X 0 0 0 KIM WILLIAMS BOARD MEMBER 3.00 X 0 0 0 BARBARA COHEN EXECUTIVE DIRECTOR 40.00 X 62000 0 0 62000 0 0 0 0 0 0 0 279830 32470 279830 3266 3266 99001 90091 8910 8910 8910 OTHER REVENUE 900099 1 1 1 292007 1 0 12176 4000 4000 62001 20667 20667 20667 4818 3373 1445 925 925 20469 20469 3792 2366 1426 18902 1888 15672 1342 4137 2715 1422 3055 2871 184 505 505 4627 3239 1388 4912 855 4057 PROMOTION 4551 207 4344 BANK FEES 2997 1703 1294 SPONSORSHIPS 2500 2500 CONTRIBUTIONS 1510 1510 958 958 144659 44474 72538 27647 264 70 91647 183823 13950 0 7126 3509 4848 4185 1252 663 153642 186210 0 21462 267881 395737 15680 6027 15680 6027 X 252201 389710 252201 389710 267881 395737 147348 -9840 0 X 0 1 X 0 0 X 96357 171988 187764 197280 279830 933219 96357 171988 187764 197280 279830 933219 933219 1526 1044 1751 1668 3266 9255 942474 0.99020 0.98890 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 4848 4185 663 663 INVESTMENTS 186210 F 186210 X 327490 -9840 45323 35483 292007 0 292007 189981 45323 45323 144658 0 144658 PART X, LINE 2: THE ORGANIZATION COMPLIES WITH THE PROVISION PERTAINING TO UNCERTAIN TAX POSITIONS AND HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. PERIODS ENDING JUNE 30, 2012 OR THEREAFTER REMAIN SUBJECT TO EXAMINATION BY APPLICABLE TAXING AUTHORITIES. X 1 32470 FAIR MARKET VALUE 0 0 0 FORM 990, PART VI, SECTION B, LINE 11 THE 990 DRAFT IS PROVIDED TO EACH BOARD MEMBER FOR COMPLETE REVIEW PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION MONITORS THEIR CONFLICT OF INTEREST POLICY AT THEIR BOARD MEETINGS. THE POLICY IS ENFORCED ON AN ONGOING BASIS. FORM 990, PART VI, SECTION B, LINE 15B THE ORGANIZATION HAS ONLY ONE EMPLOYEE WHICH IS THE EXECUTIVE DIRECTOR. THE BOARD MEETS ANNUALLY TO DISCUSS THE SALARY OF THE EXECUTIVE DIRECTOR. FORM 990, PART VI, SECTION C, LINE 19 ALL PUBLIC DOCUMENTS ARE MADE AVAILABLE UPON REQUEST AT THE ORGANIZATION'S ADDRESS OF OPERATIONS, AS WELL AS ON THEIR WEBSITE.